Johnson & Johnson’s Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec’s public drug program, even after a court ruling reinstated full coverage in January, a Reuters analysis of government data shows.
Independent experts on an FDA advisory panel on Wednesday voted against the use of an already approved diabetes drug from Eli Lilly and Co and Boehringer Ingelheim as an add-on to insulin therapy in patients with type 1 diabetes. The drug, empagliflozin, was approved in 2014 in doses of 10 mg and 20 mg to help lower blood sugar levels in patients with type 2 diabetes and is marketed as Jardiance. …read more […]
Student loan borrowers from mostly black neighborhoods are almost twice as likely to default on their debt as borrowers from neighborhoods that are mostly white, according to research released Wednesday by the Federal Reserve Bank of New York.
TORONTO/MONTREAL, Nov 13 (Reuters) – Johnson & Johnson’s Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec’s public drug program, even after a court ruling reinstated full coverage in January, a Reuters analysis of government data shows. The plan’s administrator stopped covering Remicade, J&J unit Janssen’s version of the drug infliximab, for some new patients in February 2017, in favor of cheap near-copies called biosimilars, mainly Pfizer Inc’s version of infliximab, called Inflectra. In January, a Quebec court ordered it to resume coverage. …read more […]
New York Stock Exchange affiliate NYSE Chicago has lowered its transaction fees and eliminated rebate payments following the exchange’s transition to a new technology platform, according to a regulatory filing. The move puts NYSE Chicago’s pricing structure more in line with that of a contentious plan by the U.S. Securities and Exchange Commission called the transaction fee pilot. The NYSE is suing the regulator to prevent that from taking place. …read more […]
Nike Direct President Heidi O’Neil joined Yahoo Finance’s YFi AM to talk about the swoosh brand’s continued push into digital and why it ended its pilot with Amazon. …read more […]
Global equity markets and government bond yields fell on Wednesday as sentiment soured that a U.S.-China trade deal can be reached soon and on fears intensifying unrest in Hong Kong may lead to a Chinese crackdown.
The S&P 500 and Nasdaq stock indexes slipped on Wednesday on fresh uncertainty over U.S.-China trade relations, while a jump in Walt Disney shares boosted the Dow.
Shale icon Chesapeake is reportedly in talks with Comstock Resources about selling its Haynesville shale assets which could be worth more than 1 billion dollars …read more […]
Q2 2020 Liveramp Holdings Inc Earnings Call …read more […]
Is Santander Consumer USA Holdings Inc. (NYSE:SC) a good dividend stock? How can we tell? Dividend paying companies… …read more […]
Sinclair Broadcast Group, Inc. (NASDAQ:SBGI), which is in the media business, and is based in United States, received… …read more […]
I always thought that the Vietnam War would be the worst mass killer of Americans I’d see in my lifetime. More than 58,000 American soldiers died.
But the opioid epidemic’s appalling toll amounts to nearly seven Vietnam Wars.
Opioid addiction is a national tragedy. Opioids have caused more than 400,000 deaths in America alone. And when counting the friends, family and loved ones of those victims, millions more have suffered.
It’s also a deeply personal tragedy shared by millions of Americans. I’ve written about addiction in my own family.
Enough is enough. I’m for anything that fights or reduces opioid addiction. And I mean …read more […]
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously… …read more […]
(Bloomberg) — Microsoft Corp. said Harry Shum, who oversees research and artificial intelligence at the world’s largest software maker, will leave the company in February. Chief Technology Officer Kevin Scott will take over Shum’s duties effective immediately.Shum, a 23-year Microsoft veteran with a doctorate in robotics, was one of the founding members of Microsoft’s research lab in Beijing and also ran Bing search engine product development. He plans to depart Feb. 1, and then will be an adviser to Chief Executive Officer Satya Nadella and co-founder Bill Gates, Microsoft said Wednesday in a statement.“Harry has had a profound impact on …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
